Centrica plc (LON:CNA – Get Free Report) insider Chris OShea bought 99 shares of the firm’s stock in a transaction on Thursday, September 10th. The stock was purchased at an average cost of GBX 152 per share, with a total value of £150.48.
Centrica Price Performance
CNA traded down GBX 0.20 during trading on Friday, reaching GBX 150.75. 1,058,018,500 shares of the company were exchanged, compared to its average volume of 40,663,953. Centrica plc has a 12-month low of GBX 146.79 and a 12-month high of GBX 220.30. The company’s 50-day moving average is GBX 159.77 and its two-hundred day moving average is GBX 184.15. The company has a quick ratio of 0.40, a current ratio of 1.43 and a debt-to-equity ratio of 80.68. The company has a market cap of £6.83 billion, a price-to-earnings ratio of 9.98, a P/E/G ratio of 0.45 and a beta of 0.32.
Centrica (LON:CNA – Get Free Report) last posted its earnings results on Thursday, July 23rd. The integrated energy company reported GBX 6.80 earnings per share for the quarter. Centrica had a return on equity of 21.92% and a net margin of 3.64%.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on Centrica
Centrica Company Profile
Centrica is energising a greener, fairer future for our colleagues, customers and communities. Our integrated business operates across the energy value chain, with over ten million Retail customers, leading brands such as British Gas and Bord Gáis Energy, and the UK’s largest energy services workforce. Our Infrastructure businesses bring gas and electricity to the market every day and provide more than half of the UK’s gas storage capacity, while our Optimisation business delivers world-class procurement and route-to-market capabilities to the Group and third parties, supporting energy security and our customers’ decarbonisation journeys.
See Also
- Five stocks we like better than Centrica
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Centrica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centrica and related companies with MarketBeat.com's FREE daily email newsletter.
